We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$102M
AUM Growth
+$1.94M
Cap. Flow
+$5.38M
Cap. Flow %
5.26%
Top 10 Hldgs %
10.73%
Holding
237
New
Increased
106
Reduced
61
Closed
1

Top Buys

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$653K
2
AAPL icon
Apple
AAPL
+$499K
3
LAW icon
CS Disco
LAW
+$400K
4
RCM
R1 RCM Inc. Common Stock
RCM
+$389K
5
CSV icon
Carriage Services
CSV
+$381K

Top Sells

Rank Stock Value
1
PI icon
Impinj
PI
+$587K
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$558K
3
PD icon
PagerDuty
PD
+$507K
4
IEP icon
Icahn Enterprises
IEP
+$461K
5
YELP icon
Yelp
YELP
+$427K

Sector Composition

Rank Sector Weight
1 Technology 29.57%
2 Healthcare 26.86%
3 Consumer Discretionary 11.84%
4 Industrials 9.09%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRWG icon
151
GrowGeneration
GRWG
$86.5M
$290K 0.28%
74,105
ACAD icon
152
Acadia Pharmaceuticals
ACAD
$4.43B
$290K 0.28%
18,212
-2,842
-13% -$44.4K
INTA icon
153
Intapp
INTA
$2.52B
$288K 0.28%
11,556
MDB icon
154
MongoDB
MDB
$27.1B
$282K 0.28%
1,432
+804
+128% +$143K
SDGR icon
155
Schrodinger
SDGR
$1.13B
$280K 0.27%
14,967
+6,370
+74% +$132K
PFBC icon
156
Preferred Bank
PFBC
$1.24B
$278K 0.27%
3,723
UTHR icon
157
United Therapeutics
UTHR
$25.8B
$278K 0.27%
998
MASI
158
DELISTED
Masimo
MASI
$277K 0.27%
1,871
+154
+9% +$21.2K
ARVN icon
159
Arvinas
ARVN
$518M
$275K 0.27%
8,039
SBUX icon
160
Starbucks
SBUX
$120B
$273K 0.27%
2,748
MTCH icon
161
Match Group
MTCH
$9.19B
$263K 0.26%
6,347
-552
-8% -$25K
KIM icon
162
Kimco Realty
KIM
$17.2B
$262K 0.26%
12,367
CARG icon
163
CarGurus
CARG
$3.27B
$257K 0.25%
18,342
JNPR
164
DELISTED
Juniper Networks
JNPR
$254K 0.25%
7,961
+318
+4% +$9.63K
CUBI icon
165
Customers Bancorp
CUBI
$2.66B
$254K 0.25%
8,973
HLI icon
166
Houlihan Lokey
HLI
$8.77B
$253K 0.25%
2,901
IMAX icon
167
IMAX
IMAX
$2.62B
$249K 0.24%
17,018
-2,656
-14% -$38.7K
BBIO icon
168
BridgeBio Pharma
BBIO
$15.7B
$249K 0.24%
32,669
-2,711
-8% -$26K
RLAY icon
169
Relay Therapeutics
RLAY
$4.1B
$245K 0.24%
16,428
+1,125
+7% +$21.5K
RH icon
170
RH
RH
$3.13B
$245K 0.24%
916
-5
-0.5% -$1.3K
WBA
171
DELISTED
Walgreens Boots Alliance
WBA
$241K 0.24%
6,453
-262
-4% -$9.85K
ARES icon
172
Ares Management
ARES
$28.9B
$240K 0.23%
3,500
+139
+4% +$10K
STLD icon
173
Steel Dynamics
STLD
$36B
$235K 0.23%
2,408
-98
-4% -$9.43K
CDNS icon
174
Cadence Design Systems
CDNS
$93.6B
$235K 0.23%
1,464
+125
+9% +$20K
TDOC icon
175
Teladoc Health
TDOC
$1.22B
$235K 0.23%
9,939
+755
+8% +$20.4K

Similar funds

Capital Impact Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Capital Impact Advisors held 237 positions worth $102M, up 1.9% from $100M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors deployed $5.38M of net new capital in Q4 2022, adding to 106 existing holdings.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Impinj, an estimated $587K trimmed.

  • Capital Impact Advisors added most to Exelixis in Q4 2022, an estimated $653K increase.
  • Capital Impact Advisors's biggest Q4 2022 reduction was Impinj, cutting an estimated $587K.
  • Capital Impact Advisors fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $23K.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $102M portfolio in Q4 2022.
  • Capital Impact Advisors opened 0 new positions and closed 1 in Q4 2022.
  • Capital Impact Advisors's portfolio value rose 1.9% quarter-over-quarter to $102M.

Based on Capital Impact Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.